eISSN 2288-3657
pISSN 2288-3649
pISSN 2288-3649
Fig. 6.
Fig. 6. The effects of liposomal Quer on different signaling pathways.
PC3 cells were treated with liposomal Quer, HA-modified liposomal Quer and, free Quer (10 µM) for 72 hours, isolated protein samples were then subjected to Western blotting. (A) Liposomal Quer regulates p38 MAPK, (B) p-ERK, (C) NF-ĸB p105, and (D) NF-ĸB p50. UT, untreated; LP, nanoliposomes; LP-HA, hyaluronic acid-modified nanoliposomes; Quer, quercetin; LP-Quer, quercetin-loaded nanoliposomes; LP-Quer-HA, hyaluronic acid-modified, quercetin-loaded nanoliposomes. *P < 0.001 vs. UT, #P < 0.001 vs. LP-Quer-HA, ‡P < 0.001 vs. Quer, **P < 0.001 vs. all groups.
PC3 cells were treated with liposomal Quer, HA-modified liposomal Quer and, free Quer (10 µM) for 72 hours, isolated protein samples were then subjected to Western blotting. (A) Liposomal Quer regulates p38 MAPK, (B) p-ERK, (C) NF-ĸB p105, and (D) NF-ĸB p50. UT, untreated; LP, nanoliposomes; LP-HA, hyaluronic acid-modified nanoliposomes; Quer, quercetin; LP-Quer, quercetin-loaded nanoliposomes; LP-Quer-HA, hyaluronic acid-modified, quercetin-loaded nanoliposomes. *P < 0.001 vs. UT, #P < 0.001 vs. LP-Quer-HA, ‡P < 0.001 vs. Quer, **P < 0.001 vs. all groups.
J Cancer Prev 2023;28:160~174 https://doi.org/10.15430/JCP.2023.28.4.160
© J Cancer Prev
© Korean Society of Cancer Prevention. / Powered by INFOrang Co., Ltd